A Study to Learn More About Tukysa Once it is Out in the Korean Market

Clinical trial NCT06873191 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06873191
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

HER2-positive Locally Advanced Unresectable Metastatic Breast Cancer

Start date: 2027-01-01
Primary completion: 2029-05-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.